Genetic Signatures Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. It offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. The company was incorporated in 2001 and is headquartered in Newtown, Australia.
Key Metrics
PE ratio
-
PB ratio
0.66
Dividend yield
-
Beta
0.56
Market cap
$32.94M
Enterprise value
$2.43M
Company profile
| Industry / Sector | Diagnostics & Research / Healthcare |
|---|---|
| Website | https://www.geneticsignatures.com |
| Mailing address | Heart Research Institute 7 Eliza Street Newtown NSW 2042 Australia |
| Phone / Fax | 61 2 9870 7580 / |
Dividends
More: Genetic Signatures Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Genetic Signatures paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.GSS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Genetic Signatures.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Allison Rossiter | Chief Executive Officer | ||
| Mr. Michael Anton Aicher BSc, M.B.A. | Executive Director of US Operations & Executive Director | 65 | |
| Mr. Christopher M. Abbott A.M., F.C.A., Ph.D., Ph.D., (Hon) | Founder & Chairman Emeritus | ||
| Dr. Susanne K. Pedersen Ph.D. | Chief Technology Officer | ||
| Ms. Rebecca Abbatantuono | Global Head of People & Culture |
Profitability and management effectiveness
Profit margin
-101.78%
Operating margin
-47.52%
Return on assets
-15.00%
Return on equity
-36.16%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Genetic Signatures is 32.94M and its enterprise value is 2.43M. The enterprise value to revenue ratio of GSS is 0.12. The enterprise value to EBITDA ratio of GSS is -0.19.
The GSS's stocks Beta value is 0.56 making it 44% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Genetic Signatures (GSS)
Genetic Signatures (ASX:GSS) Frequently Asked Questions
1. What is Genetic Signatures's Stock Symbol?
Genetic Signatures trades on ASX under the ticker symbol "GSS".
2. What is Genetic Signatures's stock price today?
One share of GSS stock can currently be purchased for approximately $0.145.
3. How can I contact Genetic Signatures?
Genetic Signatures's mailing address is Heart Research Institute 7 Eliza Street Newtown NSW 2042 Australia. The company can be reached via phone at 61 2 9870 7580.
4. What is Genetic Signatures's official website?
The official website of Genetic Signatures is https://www.geneticsignatures.com.